MIR · Mirion Technologies, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · MIR

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$925.40M	$860.80M	$800.90M	$717.80M	$478.20M	-
Cost of Revenue	$486.80M	$461.10M	$444.50M	$281.20M	$281.20M	-
Gross Profit	$438.60M	$399.70M	$356.40M	$310.10M	$197.00M	-
R&D	$38.90M	$35.00M	$31.70M	$30.30M	$15.90M	-
SG&A	$348.20M	$341.10M	$340.10M	$362.30M	$158.10M	$1.37M
Total Operating Expenses	$387.10M	$374.90M	$378.30M	$607.90M	$174.00M	-
D&A	$138.10M	$150.40M	$162.80M	$68.40M	$68.40M	-
Operating Income	$51.50M	$24.80M	($21.90M)	($297.80M)	$23.00M	($1.31M)
Interest Expense	$57.90M	-	$0◇	$42.50M◇	$41.20M◇	-
Income Tax	$2.90M	$2.70M	($6.60M)	($18.20M)	($5.50M)	($265.9K)
Net Income	$28.80M	($36.10M)	($96.90M)	($276.90M)	($119.10M)	($1.04M)
EPS - Basic	$0.13	($0.18)	($0.49)	($1.53)	($18.45)	-
EPS - Diluted	$0.11	($0.18)	($0.49)	($1.53)	($18.45)	-

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$412.30M	$175.20M	$128.80M	$73.50M	$101.10M	$0
Accounts Receivable	$181.60M	$177.70M	$172.30M	$171.20M	$133.30M	-
Inventory	$152.60M	$133.20M	$144.10M	$143.30M	$113.20M	-
Accounts Payable	$57.40M	$56.50M	$58.70M	$67.70M	$59.40M	$965.4K
Current Assets	$893.70M	$594.70M	$538.60M	$480.60M	$453.40M	$982.4K
Total Assets	$3.59B	$2.64B	$2.72B	$2.74B	$3.12B	$751.32M
Current Liabilities	$316.10M	$263.40M	$265.70M	$244.30M	$221.00M	$1.34M
Long-term Debt	$443.10M	$685.20M	$684.70M	$801.50M	$669.80M	-
Total Liabilities	$1.67B	$1.08B	$1.17B	$1.27B	$1.33B	$55.50M
Stockholders' Equity	$1.87B	$1.51B	$1.48B	$1.40B	$1.69B	($53.76M)
Retained Earnings	($512.70M)	($541.50M)	($505.40M)	($408.50M)	($131.60M)	($53.76M)

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$143.30M	$99.10M	$95.20M	$39.40M	$39.50M	($945.4K)
Investing Cash Flow	($694.60M)	($43.70M)	($64.70M)	($39.50M)	($75.60M)	-
Financing Cash Flow	$775.90M	($3.30M)	$22.60M	($7.00M)	$118.90M	$751.39M
CapEx	$36.40M	$48.80M	$37.10M	$34.20M	$19.90M	-
Free Cash Flow	$106.90M	$50.30M	$58.10M	$5.20M	$19.60M	-

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	47.4%	46.4%	44.5%	43.2%	41.2%	-
Operating margin	5.6%	2.9%	-2.7%	-41.5%	4.8%	-
EBITDA margin	20.5%	20.4%	17.6%	-32.0%	19.1%	-
Net margin	3.1%	-4.2%	-12.1%	-38.6%	-24.9%	-
Free cash flow margin	11.6%	5.8%	7.3%	0.7%	4.1%	-
FCF / Net income	3.71	-1.39	-0.60	-0.02	-0.16	-
R&D / Revenue	4.2%	4.1%	4.0%	4.2%	3.3%	-
SG&A / Revenue	37.6%	39.6%	42.5%	50.5%	33.1%	-
Effective tax rate	9.1%	-	-	-	-	-
Return on assets	0.8%	-1.4%	-3.6%	-10.1%	-3.8%	-0.1%
Return on equity	1.5%	-2.4%	-6.5%	-19.8%	-7.0%	1.9%
Return on invested capital	2.0%	0.9%	-0.8%	-10.7%	0.8%	-
Liquidity
Current ratio	2.83	2.26	2.03	1.97	2.05	0.73
Quick ratio	2.34	1.75	1.48	1.38	1.54	0.73
Cash ratio	1.30	0.67	0.48	0.30	0.46	0.00
Leverage
Debt / Equity	0.24	0.46	0.46	0.57	0.40	-
Debt / Assets	0.12	0.26	0.25	0.29	0.21	-
Debt / EBITDA	2.34	3.91	4.86	-	7.33	-
Interest coverage	0.9x	-	-	-7.0x	0.6x	-
Equity multiplier	1.92	1.75	1.83	1.96	1.84	-13.97
Liabilities / Assets	0.47	0.41	0.43	0.46	0.43	0.07
Efficiency
Asset turnover	0.26	0.33	0.29	0.26	0.15	-
Inventory turnover	3.19	3.46	3.08	1.96	2.48	-
Days sales outstanding	72d	75d	79d	87d	102d	-
Days inventory outstanding	114d	105d	118d	186d	147d	-
Days payable outstanding	43d	45d	48d	88d	77d	-
Cash conversion cycle	143d	136d	149d	185d	172d	-
Valuation
P / E	212.9x	-	-	-	-	-
P / B	3.3x	2.4x	1.4x	0.9x	0.0x	-
P / S	6.6x	4.2x	2.5x	1.7x	0.1x	-
EV / EBITDA	32.4x	23.3x	18.2x	-	7.0x	-
Growth
Revenue growth (YoY)	7.5%	7.5%	11.6%	50.1%	-	-
Revenue CAGR (3y)	8.8%	21.6%	-	-	-	-
Revenue CAGR (5y)	-	-	-	-	-	-
Gross profit growth (YoY)	9.7%	12.1%	14.9%	57.4%	-	-
Operating income growth (YoY)	107.7%	-	92.6%	-	-	-
Net income growth (YoY)	-	62.7%	65.0%	-132.5%	-11339.4%	-
EPS growth (YoY)	-	63.3%	68.0%	91.7%	-	-
EPS CAGR (3y)	-	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	112.5%	-13.4%	1017.3%	-73.5%	-	-
FCF CAGR (5y)	-	-	-	-	-	-
Book value growth (YoY)	24.0%	1.4%	6.2%	-17.4%	-	-

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$925.40M total

Nuclear Safety Segment$614.60M · 66.4%

Medical Segment$310.80M · 33.6%

Product / service

$1.85B total

Product$690.60M · 37.3%

Nuclear$374.60M · 20.2%

Cancer Care$237.00M · 12.8%

Service$234.80M · 12.7%

Labs And Research$122.20M · 6.6%

Other Research$117.80M · 6.4%

Other Care$73.80M · 4.0%

Geographic

$1.05B total

US$525.90M · 50.3%

North America$279.30M · 26.7%

FR$193.70M · 18.5%

Europe$31.50M · 3.0%

Asia Pacific$15.60M · 1.5%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

0.77

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

7/9

Strong

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✓Current ratio improved
✗No share dilution
✓Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Measuring & Controlling Devices, NEC

Company	Revenue (last FY)	Net margin	ROE
TMO	$44.56B	14.2%	11.9%
TRMB	$3.59B	11.8%	7.3%
ROK	-	-	-
ONTO	$1.01B	13.6%	6.5%
MASS	$56.20M	34.7%	13.6%

Comparing Mirion Technologies against the 5 most active filers in the same SIC group.

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.